Related Experiment Video
Updated: May 24, 2026

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
Published on: April 7, 2021
RDS--CPAP or surfactant or both
1Department of Neonatology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden. kajsa.bohlin@ki.se
Insights
Early continuous positive airway pressure (CPAP) is safe for preterm infants. A surfactant strategy is crucial for those at risk of respiratory distress syndrome (RDS) when using non-invasive ventilation.
Area of Science:
- Neonatal Medicine
- Pediatric Respiratory Care
Background:
- Early continuous positive airway pressure (CPAP) is increasingly recognized as a safe and feasible intervention for very preterm infants.
- Respiratory distress syndrome (RDS) remains a significant concern, often necessitating surfactant treatment even with early CPAP.
- Optimizing surfactant administration alongside non-invasive ventilation is critical but requires further investigation.
Purpose of the Study:
- To evaluate the safety and efficacy of early CPAP in very preterm neonates.
- To explore strategies for surfactant administration within a non-invasive ventilation approach.
- To identify optimal methods for surfactant delivery and the utility of predictive tests for surfactant deficiency.
Main Methods:
- Review of current evidence on early CPAP in very preterm infants.
- Analysis of strategies for surfactant administration in conjunction with non-invasive ventilation.
- Discussion of optimal timing, delivery modes, and predictive testing for surfactant deficiency.
Main Results:
- Early CPAP demonstrates comparable safety to routine intubation in the delivery room for very preterm infants.
- A significant proportion of infants receiving early CPAP still require surfactant treatment for RDS.
- The optimal approach involves integrating surfactant administration into non-invasive ventilation strategies for high-risk infants.
Conclusions:
- Early CPAP is a safe alternative to delivery room intubation for very preterm neonates.
- A proactive strategy for surfactant administration is essential for infants at risk of significant RDS when utilizing non-invasive ventilation.
- Further research is needed to refine surfactant administration protocols and predictive testing.
Unlabelled:
There is mounting evidence that early continuous positive airway pressure (CPAP) from birth is feasible and safe even in very preterm infants. However, many infants will develop respiratory distress syndrome (RDS) and require surfactant treatment. Combining a non-invasive ventilation approach with a strategy for surfactant administration is important, but questions remain about the optimal timing, mode of delivery and the value of predictive tests for surfactant deficiency.
Conclusion:
Early CPAP in very preterm infants is as safe as routine intubation in the delivery room. However, a strategy for surfactant administration should be part of a non-invasive ventilation approach for those infants at risk of developing significant RDS.
Related Concept Videos
Breathing
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III
Pulmonary Cycle: Exhalation
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
